Bausch Health vs Unilever: Founders, CEOs and History
Bausch Health was founded in 1994 by Eugene Melnyk, Milan Panic and is led by Thomas J. Appio. Unilever was founded in 1929 by William Hesketh Lever, Samuel van den Bergh, Anton Jurgens and is led by Fernando Fernandez.
Company facts
Bausch Health
- Founded
- 1994
- Headquarters
- Laval, Quebec, Canada
- Current CEO
- Thomas J. Appio
- Employees
- 20,300
Unilever
- Founded
- 1929
- Headquarters
- London, United Kingdom
- Current CEO
- Fernando Fernandez
- Employees
- 96,092
Founders
Bausch Health
Eugene Melnyk
Eugene Melnyk built Biovail into Canada's largest publicly traded pharmaceutical company, with revenue growing from about $19M in 1995 to roughly $1.07B in 2006.
Milan Panic
Milan Panic ran ICN Pharmaceuticals for four decades and made it known for the broad-spectrum antiviral ribavirin, sold as Virazole.
Unilever
William Hesketh Lever
William Hesketh Lever (later Lord Leverhulme) co-founded Lever Brothers with his brother James in 1885 and built it around Sunlight Soap, one of the first branded, individually wrapped soaps sold at mass scale.
Samuel van den Bergh
Samuel van den Bergh led Van den Bergh, a Dutch margarine maker that became one of Jurgens' main rivals. The two families combined their businesses into Margarine Unie in 1927, and Margarine Unie merged with Lever Brothers in 1929 to create Unilever.
Anton Jurgens
Anton Jurgens' family firm was among the first to manufacture margarine commercially in the Netherlands after the product was invented in France. Jurgens competed for decades with the Van den Bergh family before the two merged into Margarine Unie in 1927.
CEOs and their tenures
Bausch Health
- J. Michael Pearson2008–2016
Former Chief Executive Officer
Pearson, a former McKinsey director, became chief executive of Valeant Pharmaceuticals effective February 1, 2008 and ran the company through the September 2010 merger with Canada's Biovail until early May 2016.
Source - Joseph C. Papa2016–2022
Former Chief Executive Officer
Papa, previously chief executive of Perrigo, was named chairman and CEO in April 2016 and took over in early May 2016, inheriting about $30B of debt, an SEC investigation and congressional scrutiny of Valeant-era drug pricing.
Source - Thomas J. Appio2022–present
Chief Executive Officer
Appio became chief executive officer and a director in May 2022, succeeding Joseph Papa.
Source
Unilever
- Alan Jope2019–2023
Chief Executive Officer
Jope simplified Unilever's legal structure and organisation, which made later portfolio separations easier.
Source - Hein Schumacher2023–2025
Chief Executive Officer
Schumacher reset Unilever around fewer, bigger brands and set up the Ice Cream demerger before stepping down in February 2025.
Source - Fernando Fernandez2025–present
Chief Executive Officer
As CFO, the highly experienced Latin American executive enforces absolute financial discipline, attempting to restore investor confidence after years of sluggish stock performance.
Source
Timeline: Bausch Health and Unilever side by side
1884Unilever
Lever soap factory opens
William Hesketh Lever built the Port Sunlight soap business that became a key Unilever predecessor.
1929Unilever
Unilever created
Lever Brothers and Margarine Unie merged to form Unilever.
1929Unilever
Lever Brothers and Margarine Unie Merge
Lever Brothers and the Dutch Margarine Unie merged in 1929 to form Unilever.
1959Bausch Health
Milan Panic founds ICN Pharmaceuticals
Milan Panic, a Yugoslav immigrant to California, founded ICN Pharmaceuticals in 1959 and ran it for four decades. ICN is the predecessor of Valeant Pharmaceuticals and of today's Bausch Health.
1984Unilever
Acquired Brooke Bond
Unilever acquired Brooke Bond in 1984 for ~$515 million (£390 million).
1989Unilever
Acquired Calvin Klein Cosmetics
Unilever acquired Calvin Klein Cosmetics in 1989.
1993Unilever
Acquired Breyers
Unilever acquired Breyers in 1993.
1994Bausch Health
Biovail Corporation International formed in Canada
On March 29, 1994 Eugene Melnyk consolidated his Canadian drug-delivery business by amalgamating Trimel Corporation with its subsidiary to create Biovail Corporation International, the legal entity that files today as Bausch Health Companies Inc.
2000Unilever
Acquired Maille
Unilever acquired Maille. Unilever acquired Maille in 2000.
2003Bausch Health
ICN renames itself Valeant Pharmaceuticals
ICN Pharmaceuticals, then based in Costa Mesa, California, took the Valeant Pharmaceuticals name in November 2003 to distance itself from the governance fights of the Panic era.
2008Bausch Health
J. Michael Pearson becomes chief executive
Valeant appointed former McKinsey director J. Michael Pearson as chief executive effective February 1, 2008, succeeding Timothy C. Tyson. Pearson replaced internal research spending with debt-funded acquisitions of marketed drugs.
2010Bausch Health
Biovail and Valeant complete their merger
The merger of Biovail Corporation and Valeant Pharmaceuticals International closed on September 28, 2010. The combined company kept the Valeant name and Pearson as chief executive but was incorporated in Canada.
2011Bausch Health
Ortho Dermatologics bought from Johnson and Johnson
Valeant agreed to acquire the U.S. Ortho Dermatologics assets from Janssen Pharmaceuticals, a Johnson and Johnson company, for about $345M in cash, building the dermatology franchise.
2013Bausch Health
Bausch + Lomb acquired for $8.7 billion
Valeant agreed in May 2013 to buy eye-health company Bausch + Lomb from Warburg Pincus for $8.7B in cash, adding contact lenses, lens care, ophthalmic drugs and surgical devices.
2015Bausch Health
Salix acquisition closes at about $11.1 billion
Valeant completed its tender offer for Salix Pharmaceuticals on April 1, 2015 at $173 per share, about $11.1B in equity value and roughly $15.8B including debt, gaining the Xifaxan franchise.
2015Bausch Health
Drug pricing and Philidor scandal breaks
Congressional investigators pressed Valeant over 525% and 212% increases on the heart drugs Isuprel and Nitropress, bought in February 2015, and over its undisclosed ties to the Philidor mail-order pharmacy.
2016Bausch Health
Joseph Papa replaces Pearson as chief executive
Valeant named Perrigo chief executive Joseph C. Papa as chairman and CEO on April 25, 2016, and he took over in early May 2016 with about $30B of debt outstanding.
2017Bausch Health
Skincare brands and Dendreon sold to cut debt
Valeant sold the CeraVe, AcneFree and AMBI skincare brands to L'Oreal for about $1.3B and the Dendreon cancer unit to China's Sanpower Group for about $820M, using the proceeds to repay debt.
2018Bausch Health
Company renamed Bausch Health Companies Inc.
The name change from Valeant Pharmaceuticals International, Inc. to Bausch Health Companies Inc. was completed on July 13, 2018, and the shares began trading as BHC on the NYSE and TSX on July 16, 2018.
2019Unilever
Alan Jope becomes CEO
Alan Jope became CEO of Unilever in 2019. Jope simplified Unilever's legal structure and organisation, which made later portfolio separations easier.
2020Bausch Health
SEC settlement closes the Philidor accounting case
On July 31, 2020 Bausch Health agreed to pay a $45M civil penalty to settle SEC charges of improper revenue recognition and misleading disclosures tied to Philidor. Former chief executive J. Michael Pearson and two other executives also settled.
2020Unilever
Legal structure unified
Unilever moved to a single parent company structure after decades with British and Dutch holding companies.
2020Unilever
Single Parent Company
Unilever unified its dual structure into a single parent company, Unilever PLC, in November 2020.
2022Bausch Health
Bausch + Lomb listed on the NYSE and TSX
Bausch + Lomb common stock began trading under the ticker BLCO on May 6, 2022, and a Bausch Health subsidiary sold 35,000,000 Bausch + Lomb shares in the offering. Bausch Health retained about 88% of the eye-health company and still consolidates it. Thomas J.
2025Bausch Health
DURECT acquired and record annual revenue reported
Bausch Health closed the DURECT acquisition on September 11, 2025 for about $63M upfront, completed Solta Medical's Chinese aesthetics distribution purchase on December 1, 2025, and reported FY2025 revenue of $10.266B, up 7%, with net income attributable to Ba…
2025Unilever
Fernando Fernandez becomes CEO
Fernando Fernandez was appointed CEO effective March 2025.
2025Unilever
Ice Cream demerger reflected
Unilever reported 2025 results on a continuing-operations basis after the Ice Cream business demerger.
2026Bausch Health
RED-C trials miss endpoints and trigger a $1.4 billion charge
In January 2026 the two Phase 3 RED-C trials of amorphous-rifaximin soluble solid dispersion for primary prevention of hepatic encephalopathy missed their primary endpoints.
2026Bausch Health
Second-quarter 2026 revenue of $2.85 billion and raised guidance
Bausch Health reported second-quarter 2026 revenue of $2.85B, up 13%, net income attributable to Bausch Health of $258M and adjusted EBITDA of $1.075B, and raised its full-year 2026 revenue, adjusted EBITDA and cash flow guidance.
Acquisitions
Bausch Health
- DURECT Corporation2025$63M
- Shibo Zhenmei aesthetics distribution business2025Undisclosed
- Salix Pharmaceuticals2015$11.1B
- Bausch + Lomb Holdings2013$8.7B
- Ortho Dermatologics2011$345M
Unilever
- Dr. Squatch2025Undisclosed
- Wild2025Undisclosed
- Minimalist2025Undisclosed
- Paula's Choice2021Undisclosed
- Sir Kensington's2017Undisclosed
- Weis2017Undisclosed
Questions about Bausch Health vs Unilever
Who is the CEO of Bausch Health Companies Inc. and Unilever PLC?
Bausch Health Companies Inc. is led by Thomas J. Appio and Unilever PLC is led by Fernando Fernandez. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Bausch Health Companies Inc. founded vs Unilever PLC?
Unilever PLC was founded in 1929 — 65 years before Bausch Health Companies Inc., which was founded in 1994. Unilever PLC's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Bausch Health Companies Inc..
How many employees does Bausch Health Companies Inc. have compared to Unilever PLC?
Bausch Health Companies Inc. employs approximately 20,300 people, while Unilever PLC employs approximately 96,092. Unilever PLC has the larger workforce at 96,092 employees, compared to Bausch Health Companies Inc.'s 20,300. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Bausch Health Companies Inc. and Unilever PLC headquartered?
Bausch Health Companies Inc. is headquartered in Canada and Unilever PLC is headquartered in United Kingdom. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Bausch Health Companies Inc. and Unilever PLC?
Bausch Health Companies Inc. was founded by Eugene Melnyk, Milan Panic. Unilever PLC was founded by William Hesketh Lever, Samuel van den Bergh, Anton Jurgens.
Which company has a longer operating history — Bausch Health Companies Inc. or Unilever PLC?
Unilever PLC has been operating for approximately 97 years, making it the more established of the two companies. Bausch Health Companies Inc. has been in operation for around 32 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Bausch Health vs Unilever overview